1-6 of 6
Douglas D. Ross
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia

Ivana Gojo, Ming Tan, Hong-Bin Fang, Mariola Sadowska, Rena Lapidus, Maria R. Baer, France Carrier, Jan H. Beumer, Bean N. Anyang, Rakesh K. Srivastava, Igor Espinoza-Delgado, Douglas D. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (7): 1838–1851.
https://doi.org/10.1158/1078-0432.CCR-12-3165
Published: 02 April 2013
View article titled, Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia
Open the PDF for Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias

Ken Shiozawa, Takeo Nakanishi, Ming Tan, Hong-Bin Fang, Wen-chyi Wang, Martin J. Edelman, David Carlton, Ivana Gojo, Edward A. Sausville, Douglas D. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (5): 1698–1707.
https://doi.org/10.1158/1078-0432.CCR-08-1587
Published: 27 February 2009
View article titled, Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias
Open the PDF for Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias in another window
Includes: Supplementary data
Journal Articles

Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-d-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias

Judith E. Karp, Antonino Passaniti, Ivana Gojo, Scott Kaufmann, Keith Bible, Tushar S. Garimella, Jacqueline Greer, Janet Briel, B. Douglas Smith, Steven D. Gore, Michael L. Tidwell, Douglas D. Ross, John J. Wright, A. Dimitrios Colevas, Kenneth S. Bauer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8403–8412.
https://doi.org/10.1158/1078-0432.CCR-05-1201
Published: 01 December 2005
View article titled, Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-<sc>d</sc>-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias
Open the PDF for Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-<sc>d</sc>-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias in another window
Journal Articles

Quantitative Analysis of Breast Cancer Resistance Protein and Cellular Resistance to Flavopiridol in Acute Leukemia Patients

Takeo Nakanishi, Judith E. Karp, Ming Tan, L. Austin Doyle, Todd Peters, Weidong Yang, David Wei, Douglas D. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3320–3328.
Published: 05 September 2003
View article titled, Quantitative Analysis of Breast Cancer Resistance Protein and Cellular Resistance to Flavopiridol in Acute Leukemia Patients
Open the PDF for Quantitative Analysis of Breast Cancer Resistance Protein and Cellular Resistance to Flavopiridol in Acute Leukemia Patients in another window
Journal Articles

Timed Sequential Therapy of Acute Leukemia with Flavopiridol: In Vitro Model for a Phase I Clinical Trial

Judith E. Karp, Douglas D. Ross, Weidong Yang, Michael L. Tidwell, Yuetong Wei, Jacqueline Greer, Dean L. Mann, Takeo Nakanishi, John J. Wright, A. Dmitri Colevas
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 307–315.
Published: 01 January 2003
View article titled, Timed Sequential Therapy of Acute Leukemia with Flavopiridol: <subtitle> <em>In Vitro</em> Model for a Phase I Clinical Trial</subtitle>
Open the PDF for Timed Sequential Therapy of Acute Leukemia with Flavopiridol: <subtitle> <em>In Vitro</em> Model for a Phase I Clinical Trial</subtitle> in another window
Journal Articles

Overexpression of the ATP-binding Cassette Half-Transporter, ABCG2 (MXR/BCRP/ABCP1), in Flavopiridol-resistant Human Breast Cancer Cells

Robert W. Robey, Wilma Y. Medina-Pérez, Kenryu Nishiyama, Tyler Lahusen, Keisuke Miyake, Thomas Litman, Adrian M. Senderowicz, Douglas D. Ross, Susan E. Bates
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (1): 145–152.
Published: 01 January 2001
View article titled, Overexpression of the ATP-binding Cassette Half-Transporter, ABCG2 (MXR/BCRP/ABCP1), in Flavopiridol-resistant Human Breast Cancer Cells
Open the PDF for Overexpression of the ATP-binding Cassette Half-Transporter, ABCG2 (MXR/BCRP/ABCP1), in Flavopiridol-resistant Human Breast Cancer Cells in another window